SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

CAPR.O (CAPR.O) News

Track canonical SquawkNews coverage tagged to CAPR.O, CAPR.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol CAPR.O Asset market Sector Markets 90 days 1 Updated Sep 30, 2026, 03:07 PM UTC Open live news feed
M Capricor Therapeutics rises 12.8% after positive Duchenne drug data Capricor Therapeutics shares rose 12.8% to $9.67 after 24-month open-label extension data from its Duchenne drug trial was presented at the World Muscle Society Congress. B. Riley Securities maintained a "buy" rating and EQUITY | Sep 30, 2026, 03:07 PM UTC